Cox regression model for survival in patients given gemtuzumab ozogamicin with or without interleukin 11
| Variable . | Coefficient estimate . | Standard error . | P . |
|---|---|---|---|
| Normal karyotype | −1.268 | 0.467 | .007 |
| AHD present (rather than absent) | −1.078 | 0.433 | .013 |
| Increasing age (numerical) | 0.102 | 0.044 | .019 |
| Received interleukin 11 | 0.007 | 0.435 | .99 |
| Variable . | Coefficient estimate . | Standard error . | P . |
|---|---|---|---|
| Normal karyotype | −1.268 | 0.467 | .007 |
| AHD present (rather than absent) | −1.078 | 0.433 | .013 |
| Increasing age (numerical) | 0.102 | 0.044 | .019 |
| Received interleukin 11 | 0.007 | 0.435 | .99 |
AHD indicates antecedent hematologic disorder.